Clinical trial · Observational
Viral Reactivation and Skin Cancer
Association of Viral Reactivation and Skin Cancer in Organ Transplant Recipients
NCT02395562CI-TRIAL-00023026completedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Several studies show that the incidence of skin cancer parallels the length and depth of immunosuppression. This study will analyze the correlation of viral reactivation and skin cancer in organ transplant recipients.
Conditions
Conditions (2)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Infection Reactivation | — | UNRESOLVED | — |
| Skin Cancer | Malignant Skin Neoplasm | ALIAS | 0.90 |
Interventions
Interventions (0)
Data not yet available
No intervention recorded.
Design
Arms and outcomes
Arms (1)
- label
- OTR and viral reactivation
- description
- Organ transplant recipients with and without viral reactivation and skin cancer
Primary outcomes (1)
- measure
- The correlation of skin cancer with viral reactivation in organ transplant recipients
- timeFrame
- 10 years
Secondary outcomes (1)
- measure
- The association of viral reactivation and infection in the first year and skin cancer in the following years. Can one be used as a marker for the other one?
- timeFrame
- 10 years
Eligibility
Eligibility (as posted)
- Sex
- All
Show eligibility criteria text
Inclusion Criteria: * oral and written consent to inclusion * recipient of solid organ transplant Exclusion Criteria: * withdrawal of inform consent
References
Publications (0)
Data not yet available
No reference posted for this study.